Trial Profile
Combination therapy with peginterferon lambda-1a and entecavir in patients with HBeAg-positive chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Peginterferon lambda-1a (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors Bristol-Myers Squibb
- 08 Dec 2015 New trial record